Inceptor Bio is a clinical-stage biotechnology company focused on developing next-generation cell therapies. The company is dedicated to addressing unmet medical needs, exemplified by its lead program, IB-T101, which targets clear cell Renal Cell Carcinoma (ccRCC).
Leadership & Board
Current Number of Employees20
Current LinkedIn Followers5,256
Latest Estimated Valuation
Estimated Valuation―
Estimated Valuation―
Total Amount Raised$21M
Total Amount Raised$21M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$21M
Latest Funding Amount$21M
Latest Funding RoundSeries A
Latest Funding RoundSeries A
Post-Money Valuation―
Post-Money Valuation―
Employee Trend
Inceptor Bio had 20 employees as of September 21, 2026. The number of employees increased by 0 (0.00%) week-over-week.
20Latest Employee Count
0(0.00%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.
Social Trend
Inceptor Bio had 5,256 followers as of September 21, 2026. The number of followers increased by 5 (0.10%) week-over-week.
5,256Latest Followers Count
5(0.10%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.
Funding Round
Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Feb 25, 2025
Series A
$21.00M
―
Similar Companies
A snapshot of private companies similar to Inceptor Bio, helping you discover and navigate related company profiles.